Market Overview:
The global sterile intravenous (IV) solution market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of chronic diseases, rising geriatric population, and technological advancements in the field of IV solutions. Based on type, the global sterile intravenous (IV) solution market is segmented into crystalloids, colloids, and others. Crystalloids are further sub-segmented into isotonic crystalloid solutions and hypotonic crystalloid solutions. Colloids are further sub-segmented into hydroxyethyl starch (HES), dextranomer/polysaccharide copolymer (DxP), gelatin/heparin sulfate complexes (Gel/HS), and others. The crytalloid segment is expected to dominate the global sterile intravenous solution market during the forecast period owing to its high usage in various applications such as medications, nutritionals & hydration therapy products,, blood product transfusions,, dialysis patients,, cancer patients undergoing chemotherapy,, etc.
 Solution Industry Outlook.svg)
Product Definition:
A sterile intravenous (IV) solution is a fluid that is used to inject fluids, medications, or other treatments directly into a vein. The solution is typically sterile and can be used to provide hydration, deliver medications, or perform other medical procedures. The importance of using a sterile IV solution depends on the particular situation. For example, using a sterile IV solution may be necessary for delivering medications or performing certain medical procedures. Additionally, using a sterile IV solution can help reduce the risk of infection.
Crystalloids:
Crystalloids are colloidal particles that have a large surface area and are made up of organic compounds. Crystalloid solutions include both synthetic as well as natural colloidal particles. The most commonly used crystalloid solution is sterile intravenous (IV) infusion, which is also known as crystallization or IV fluid.
Crystalloids have been in use for many years in the form of intravenous fluids.
Colloids:
Colloids are particles that remain suspended in a liquid and have a characteristic of exhibiting elasticity when bent or broken. The most common types of colloids used in the pharmaceutical industry include dextrose, lactose, starch, gelatin and carboxymethyl cellulose among others. Colloid products are widely utilized as stabilizers and thickeners for intravenous solutions (IV solutions), which is expected to be one of the key factors driving market growth over the forecast period.
Application Insights:
Based on the application, the global sterile intravenous (IV) solution market is segmented into medications, nutrition, blood-based products and others. The blood-based products segment dominated the overall market in terms of revenue share in 2017. Increasing demand for IV solutions from hospitals and healthcare centers for various medical procedures is anticipated to drive growth over the forecast period.
The medications segment is anticipated to witness significant growth during the forecast period owing to increasing usage of these solutions across hospital settings as well as clinical applications. In addition, an increase in hospital admissions due to a rise in chronic diseases such as cancer is expected to boost product demand during the forecast period.
Increasing adoption of advanced technologies coupled with rising disposable income levels has led towards increased consumption of smartphones globally which has positively influenced consumer purchasing behavior regarding healthcare services including medication.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of well-established healthcare infrastructure, high patient awareness levels coupled with relatively higher healthcare spending levels in this region. Moreover, increasing R&D investments by major players for development of advanced products is also expected to drive growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to rising disposable income and improving economic conditions in emerging countries such as India and China. In addition, an increase in medical tourism due to affordable treatment options will also boost demand for sterile intravenous solutions over the next eight years.
Growth Factors:
- Increasing incidence of chronic diseases: The prevalence of chronic diseases is increasing at an alarming rate across the globe. This is primarily because of the changing lifestyle and dietary habits. The increase in the number of patients with chronic diseases will lead to an increase in demand for sterile IV solutions.
- Technological advancements: There has been a significant advancement in technology over the past few years, which has led to the development of new and innovative products in the sterile IV solution market. This is likely to fuel growth in this market over the forecast period.
- Rising geriatric population: The global geriatric population is growing at a rapid pace and this is expected to drive demand for sterile IV solutions during the forecast period. Elderly patients are more susceptible to various infections and require intravenous treatment for proper management of their health conditions, thereby leading to an increase in demand for these solutions.
Scope Of The Report
Report Attributes
Report Details
Report Title
Sterile Intravenous (IV) Solution Market Research Report
By Type
Crystalloids, Colloids, Others,
By Application
Medications, NutritionNutrition, Blood-based Products, Others,
By Companies
B. Braun Medical Inc., Technoflex, Baxter International, ICU Medical, Inc, Mckesson, Amsino, Wallcur, Hebei Guangren Pharmaceutical Technology, Jiangsu Hengfengqiang Biotechnology, Hospira, Jiangsu Hengfengqiang Biotechnology, Hospira, Xi'an Libang Alliance Enterprise Management, Livzon Group,
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Sterile Intravenous (IV) Solution Market Report Segments:
The global Sterile Intravenous (IV) Solution market is segmented on the basis of:
Types
Crystalloids, Colloids, Others,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medications, NutritionNutrition, Blood-based Products, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- B. Braun Medical Inc.
- Technoflex
- Baxter International
- ICU Medical, Inc
- Mckesson
- Amsino
- Wallcur
- Hebei Guangren Pharmaceutical Technology
- Jiangsu Hengfengqiang Biotechnology
- Hospira
- Jiangsu Hengfengqiang Biotechnology
- Hospira
- Xi'an Libang Alliance Enterprise Management
- Livzon Group
 Solution Market Overview.svg)
Highlights of The Sterile Intravenous (IV) Solution Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Crystalloids
- Colloids
- Others
- By Application:
- Medications
- NutritionNutrition
- Blood-based Products
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sterile Intravenous (IV) Solution Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Solution Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A sterile intravenous (IV) solution is a liquid that is used to give fluids and other medications through a vein. It is made up of water, saline, and other ingredients that help keep the solution clean. IV solutions are often given to patients in hospitals or clinics.
Some of the key players operating in the sterile intravenous (iv) solution market are B. Braun Medical Inc., Technoflex, Baxter International, ICU Medical, Inc, Mckesson, Amsino, Wallcur, Hebei Guangren Pharmaceutical Technology, Jiangsu Hengfengqiang Biotechnology, Hospira, Jiangsu Hengfengqiang Biotechnology, Hospira, Xi'an Libang Alliance Enterprise Management, Livzon Group.
The sterile intravenous (iv) solution market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Sterile Intravenous (IV) Solution Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Sterile Intravenous (IV) Solution Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Sterile Intravenous (IV) Solution Market - Supply Chain
4.5. Global Sterile Intravenous (IV) Solution Market Forecast
4.5.1. Sterile Intravenous (IV) Solution Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Sterile Intravenous (IV) Solution Market Size (000 Units) and Y-o-Y Growth
4.5.3. Sterile Intravenous (IV) Solution Market Absolute $ Opportunity
5. Global Sterile Intravenous (IV) Solution Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Sterile Intravenous (IV) Solution Market Size and Volume Forecast by Type
5.3.1. Crystalloids
5.3.2. Colloids
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Sterile Intravenous (IV) Solution Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Sterile Intravenous (IV) Solution Market Size and Volume Forecast by Application
6.3.1. Medications
6.3.2. NutritionNutrition
6.3.3. Blood-based Products
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Sterile Intravenous (IV) Solution Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Sterile Intravenous (IV) Solution Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Sterile Intravenous (IV) Solution Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Sterile Intravenous (IV) Solution Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Sterile Intravenous (IV) Solution Demand Share Forecast, 2019-2026
9. North America Sterile Intravenous (IV) Solution Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Sterile Intravenous (IV) Solution Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Sterile Intravenous (IV) Solution Market Size and Volume Forecast by Application
9.4.1. Medications
9.4.2. NutritionNutrition
9.4.3. Blood-based Products
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Sterile Intravenous (IV) Solution Market Size and Volume Forecast by Type
9.7.1. Crystalloids
9.7.2. Colloids
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Sterile Intravenous (IV) Solution Demand Share Forecast, 2019-2026
10. Latin America Sterile Intravenous (IV) Solution Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Sterile Intravenous (IV) Solution Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Sterile Intravenous (IV) Solution Market Size and Volume Forecast by Application
10.4.1. Medications
10.4.2. NutritionNutrition
10.4.3. Blood-based Products
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Sterile Intravenous (IV) Solution Market Size and Volume Forecast by Type
10.7.1. Crystalloids
10.7.2. Colloids
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Sterile Intravenous (IV) Solution Demand Share Forecast, 2019-2026
11. Europe Sterile Intravenous (IV) Solution Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Sterile Intravenous (IV) Solution Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Sterile Intravenous (IV) Solution Market Size and Volume Forecast by Application
11.4.1. Medications
11.4.2. NutritionNutrition
11.4.3. Blood-based Products
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Sterile Intravenous (IV) Solution Market Size and Volume Forecast by Type
11.7.1. Crystalloids
11.7.2. Colloids
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Sterile Intravenous (IV) Solution Demand Share, 2019-2026
12. Asia Pacific Sterile Intravenous (IV) Solution Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Sterile Intravenous (IV) Solution Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Sterile Intravenous (IV) Solution Market Size and Volume Forecast by Application
12.4.1. Medications
12.4.2. NutritionNutrition
12.4.3. Blood-based Products
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Sterile Intravenous (IV) Solution Market Size and Volume Forecast by Type
12.7.1. Crystalloids
12.7.2. Colloids
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Sterile Intravenous (IV) Solution Demand Share, 2019-2026
13. Middle East & Africa Sterile Intravenous (IV) Solution Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Sterile Intravenous (IV) Solution Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Sterile Intravenous (IV) Solution Market Size and Volume Forecast by Application
13.4.1. Medications
13.4.2. NutritionNutrition
13.4.3. Blood-based Products
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Sterile Intravenous (IV) Solution Market Size and Volume Forecast by Type
13.7.1. Crystalloids
13.7.2. Colloids
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Sterile Intravenous (IV) Solution Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Sterile Intravenous (IV) Solution Market: Market Share Analysis
14.2. Sterile Intravenous (IV) Solution Distributors and Customers
14.3. Sterile Intravenous (IV) Solution Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. B. Braun Medical Inc.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Technoflex
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Baxter International
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. ICU Medical, Inc
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Mckesson
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Amsino
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Wallcur
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Hebei Guangren Pharmaceutical Technology
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Jiangsu Hengfengqiang Biotechnology
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Hospira
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Jiangsu Hengfengqiang Biotechnology
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Hospira
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Xi'an Libang Alliance Enterprise Management
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Livzon Group
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15.
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
